| Prostate — USPSTF 2018 final statement | At ages 55–69, PSA screening is an individual decision after discussing benefits and harms. USPSTF recommends against routine PSA screening at 70+. | The source lists an update in progress. It does not establish an earlier start for every higher-risk group; discuss family history and other risks. False positives, biopsy, overdiagnosis and treatment complications matter. This guidance is for people without symptoms or previous prostate cancer. |
| Testicular — USPSTF 2011 | USPSTF recommends against routine screening by clinician exam or self-exam in asymptomatic adolescent and adult males. | This does not mean ignore a new lump, pain or change. The review did not assess people with a history of an undescended testicle; discuss individual history. |
| Colorectal — USPSTF 2021 | Average-risk adults: screening at 45–75; individual decisions at 76–85. Several methods are available. | Colonoscopy is not the only option. Prior polyps, inflammatory bowel disease, hereditary risk or symptoms need a separate plan. Agree the chosen method and required follow-up. |
| Blood pressure — USPSTF 2021 | Screen adults 18+. Annual screening is suggested at 40+ or increased risk; 3–5 years can fit low-risk ages 18–39 with a prior normal reading. | An elevated office reading generally needs confirmation outside the clinic before treatment. Ask which method and interval fit your history. |